Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.32 USD | +0.22% | -25.50% | +12.42% |
05-09 | Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating | MT |
05-08 | Transcript : LifeMD, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.42% | 381M | |
+5.85% | 32.93B | |
+20.16% | 7.94B | |
+30.81% | 4.19B | |
-25.95% | 2.8B | |
-19.96% | 1.38B | |
-31.87% | 1.17B | |
+8.02% | 966M | |
-35.73% | 900M | |
-25.74% | 839M |
- Stock Market
- Equities
- LFMD Stock
- News LifeMD, Inc.
- BTIG Research Adjusts LifeMD Price Target to $7 From $8, Maintains Buy Rating